×
返回 Agenda
Session 1: Status on implementation of the CTR and how to keep momentum
Session Chair(s)
Nick Sykes, MS
Policy Advisor, Regulatory Strategy
EFPIA, Belgium
Status on implementation of the CTR and how to keep momentum
Speaker(s)
Latest Status of the CTReg
Judith Creba, PHD
Novartis Pharma AG, Switzerland
Sr. Global Program Regulatory Director, Reg Affairs GDD Region EU
Panel Discussion with Q&A from Audience
Elke Stahl, PHD
Federal Institute For Drugs and Medical Devices (BfArM), Germany
Senior Expert, Clinical Trials Department
Judith Creba, PHD
Novartis Pharma AG, Switzerland
Sr. Global Program Regulatory Director, Reg Affairs GDD Region EU
Stéphanie Kromar
European Organisation for Research and Treatment of Cancer (EORTC) , Belgium
Senior Regulatory Affairs Manager
Sini Eskola, MPHARM, MS, MSC
Takeda, Belgium
Head of International Regulatory Policy and Innovation
Monique Al, PHD
Central Committee on Research Involving Human Subjects (CCMO), Netherlands
Special advisor CCMO